Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, an International, Post-Marketing Surveillance Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, an International, Post-Marketing Surveillance Study

Published:2024-03 Issue: Volume:Volume 18 Page:667-684
ISSN:1177-8881
Container-title:Drug Design, Development and Therapy
language:en
Short-container-title:DDDT

Author:

Loche Sandro,Kanumakala Shankar,Backeljauw Philippe,Schwab Karl,Lechuga-Sancho Alfonso,Esmael Altaher,Urosevic Dragan,Boldea Anca,Zabransky Markus

Publisher

Informa UK Limited

Reference32 articles.

1. European Medicines Agency [Internet]. Omnitrope® summary of product characteristics, updated 2023; 2008. Available from: https://www.ema.europa.eu/en/documents/product-information/omnitrope-epar-product-information_en.pdf. Accessed June 30, 2023.

2. The history, physiology and treatment safety of growth hormone

3. Growth hormone — past, present and future

4. Growth, Endocrine Features, and Growth Hormone Treatment in Noonan Syndrome

5. European Medicines Agency [Internet]. Omnitrope® European public assessment report (EPAR), updated 2018; 2008. Available from: https://www.ema.europa.eu/en/documents/overview/omnitrope-epar-summary-public_en.pdf. Accessed June 30, 2023.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP